View ValuationNovoray 향후 성장Future 기준 점검 6/6Novoray (는) 각각 연간 40.3% 및 28% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 40.2% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 26.6% 로 예상됩니다.핵심 정보40.3%이익 성장률40.22%EPS 성장률Chemicals 이익 성장28.6%매출 성장률28.0%향후 자기자본이익률26.62%애널리스트 커버리지Low마지막 업데이트17 Jul 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesReported Earnings • Aug 17Second quarter 2026 earnings released: EPS: CN¥0.32 (vs CN¥0.31 in 2Q 2025)Second quarter 2026 results: EPS: CN¥0.32 (up from CN¥0.31 in 2Q 2025). Revenue: CN¥335.4m (up 20% from 2Q 2025). Net income: CN¥77.4m (up 2.3% from 2Q 2025). Profit margin: 23% (down from 27% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 73% per year, which means it is tracking significantly ahead of earnings growth.공고 • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026Declared Dividend • Jun 06Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 10th June 2026 Payment date: 10th June 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not adequately covered by cash flows (91% cash payout ratio). The dividend has increased by an average of 19% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 38% over the next year, which should provide support to the dividend and adequate earnings cover.Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Fan Wu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Apr 22Novoray Corporation, Annual General Meeting, May 18, 2026Novoray Corporation, Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: 2F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China공고 • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026공고 • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026공고 • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025공고 • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025공고 • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025공고 • Mar 26Novoray Corporation, Annual General Meeting, Apr 17, 2025Novoray Corporation, Annual General Meeting, Apr 17, 2025, at 14:00 China Standard Time. Location: 3F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China공고 • Dec 27Novoray Corporation to Report Fiscal Year 2024 Results on Mar 26, 2025Novoray Corporation announced that they will report fiscal year 2024 results on Mar 26, 2025Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥57.50, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 23% over the past year.Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.28 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.37 (up from CN¥0.28 in 3Q 2023). Revenue: CN¥250.4m (up 27% from 3Q 2023). Net income: CN¥67.4m (up 30% from 3Q 2023). Profit margin: 27% (in line with 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.공고 • Sep 30Novoray Corporation to Report Q3, 2024 Results on Oct 31, 2024Novoray Corporation announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥44.57, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.8% over the past year.Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.35 (up from CN¥0.23 in 2Q 2023). Revenue: CN¥241.1m (up 43% from 2Q 2023). Net income: CN¥65.8m (up 49% from 2Q 2023). Profit margin: 27% (up from 26% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.공고 • Jun 28Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024Novoray Corporation announced that they will report first half, 2024 results on Aug 26, 2024Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.28 (up from CN¥0.15 in 1Q 2023). Revenue: CN¥202.3m (up 40% from 1Q 2023). Net income: CN¥51.7m (up 80% from 1Q 2023). Profit margin: 26% (up from 20% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.공고 • Mar 29Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024Novoray Corporation announced that they will report Q1, 2024 results on Apr 26, 2024공고 • Mar 26Novoray Corporation, Annual General Meeting, Apr 19, 2024Novoray Corporation, Annual General Meeting, Apr 19, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Lianyungang, Jiangsu ChinaReported Earnings • Mar 26Full year 2023 earnings released: EPS: CN¥0.94 (vs CN¥1.01 in FY 2022)Full year 2023 results: EPS: CN¥0.94 (down from CN¥1.01 in FY 2022). Revenue: CN¥711.7m (up 7.5% from FY 2022). Net income: CN¥174.0m (down 7.6% from FY 2022). Profit margin: 24% (down from 28% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥35.60, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 13x in the Chemicals industry in China.Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥57.99, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 16x in the Chemicals industry in China.Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥196.7m (up 43% from 3Q 2022). Net income: CN¥51.8m (up 33% from 3Q 2022). Profit margin: 26% (down from 28% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥169.1m (down 2.4% from 2Q 2022). Net income: CN¥44.3m (down 11% from 2Q 2022). Profit margin: 26% (down from 29% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Buying Opportunity • Aug 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥53.21, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 76% in 2 years. Earnings is forecast to grow by 94% in the next 2 years.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥51.75, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 16x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥44.12 per share.Reported Earnings • May 02First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.34 in 1Q 2022). Revenue: CN¥145.0m (down 18% from 1Q 2022). Net income: CN¥28.7m (down 33% from 1Q 2022). Profit margin: 20% (down from 24% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 32%After last week's 32% share price gain to CN¥87.58, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Chemicals industry in China.Board Change • Mar 15Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Dong Hui Pan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.이익 및 매출 성장 예측XSSC:688300 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20282,547909N/A761112/31/20271,979631N/A575212/31/20261,545446N/A37826/30/20261,226303140268N/A3/31/20261,171301133233N/A12/31/20251,116293157255N/A9/30/20251,090287167263N/A6/30/20251,036273103200N/A3/31/2025997263191291N/A12/31/2024960251165255N/A9/30/2024895234167248N/A6/30/2024841218164236N/A3/31/2024769197137189N/A12/31/2023712174194247N/A9/30/2023685182139203N/A6/30/2023625169156248N/A3/31/2023630174130277N/A12/31/202266218886241N/A9/30/202265717524213N/A6/30/2022686186-47161N/A3/31/2022663179-64117N/A12/31/2021625173-55153N/A9/30/2021581169-94117N/A6/30/2021522147-42135N/A3/31/2021473130-57104N/A12/31/2020404111-3490N/A9/30/2020367921998N/A6/30/2020341822995N/A3/31/202032178N/A100N/A12/31/201931575N/A81N/A9/30/201929869N/A97N/A6/30/201929267N/A70N/A3/31/201927760N/A53N/A12/31/201827858N/A56N/A9/30/201826454N/A34N/A6/30/201824950N/A12N/A3/31/201823046N/A9N/A12/31/201721142N/A6N/A9/30/201719341N/A17N/A6/30/201717639N/A27N/A3/31/201716536N/A22N/A12/31/201615433N/A18N/A9/30/201614327N/AN/AN/A6/30/201613220N/A16N/A3/31/201612719N/A12N/A12/31/201512218N/A7N/A9/30/201512119N/A3N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 688300 의 연간 예상 수익 증가율(40.3%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 688300 의 연간 수익(40.3%)이 CN 시장(26.3%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: 688300 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 688300 의 수익(연간 28%)이 CN 시장(연간 16.9%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 688300 의 수익(연간 28%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 688300의 자본 수익률은 3년 후 26.6%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/24 18:46종가2026/08/24 00:00수익2026/06/30연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Novoray Corporation는 3명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Yilin HouChina International Capital Corporation LimitedChao LiCitic Securities Co., Ltd.Wei LiuHaitong International Research Limited
Reported Earnings • Aug 17Second quarter 2026 earnings released: EPS: CN¥0.32 (vs CN¥0.31 in 2Q 2025)Second quarter 2026 results: EPS: CN¥0.32 (up from CN¥0.31 in 2Q 2025). Revenue: CN¥335.4m (up 20% from 2Q 2025). Net income: CN¥77.4m (up 2.3% from 2Q 2025). Profit margin: 23% (down from 27% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 73% per year, which means it is tracking significantly ahead of earnings growth.
공고 • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026
Declared Dividend • Jun 06Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 10th June 2026 Payment date: 10th June 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not adequately covered by cash flows (91% cash payout ratio). The dividend has increased by an average of 19% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 38% over the next year, which should provide support to the dividend and adequate earnings cover.
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Fan Wu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Apr 22Novoray Corporation, Annual General Meeting, May 18, 2026Novoray Corporation, Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: 2F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China
공고 • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026
공고 • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026
공고 • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025
공고 • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025
공고 • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025
공고 • Mar 26Novoray Corporation, Annual General Meeting, Apr 17, 2025Novoray Corporation, Annual General Meeting, Apr 17, 2025, at 14:00 China Standard Time. Location: 3F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China
공고 • Dec 27Novoray Corporation to Report Fiscal Year 2024 Results on Mar 26, 2025Novoray Corporation announced that they will report fiscal year 2024 results on Mar 26, 2025
Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥57.50, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 23% over the past year.
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.28 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.37 (up from CN¥0.28 in 3Q 2023). Revenue: CN¥250.4m (up 27% from 3Q 2023). Net income: CN¥67.4m (up 30% from 3Q 2023). Profit margin: 27% (in line with 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
공고 • Sep 30Novoray Corporation to Report Q3, 2024 Results on Oct 31, 2024Novoray Corporation announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥44.57, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.8% over the past year.
Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.35 (up from CN¥0.23 in 2Q 2023). Revenue: CN¥241.1m (up 43% from 2Q 2023). Net income: CN¥65.8m (up 49% from 2Q 2023). Profit margin: 27% (up from 26% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
공고 • Jun 28Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024Novoray Corporation announced that they will report first half, 2024 results on Aug 26, 2024
Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.28 (up from CN¥0.15 in 1Q 2023). Revenue: CN¥202.3m (up 40% from 1Q 2023). Net income: CN¥51.7m (up 80% from 1Q 2023). Profit margin: 26% (up from 20% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
공고 • Mar 29Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024Novoray Corporation announced that they will report Q1, 2024 results on Apr 26, 2024
공고 • Mar 26Novoray Corporation, Annual General Meeting, Apr 19, 2024Novoray Corporation, Annual General Meeting, Apr 19, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Lianyungang, Jiangsu China
Reported Earnings • Mar 26Full year 2023 earnings released: EPS: CN¥0.94 (vs CN¥1.01 in FY 2022)Full year 2023 results: EPS: CN¥0.94 (down from CN¥1.01 in FY 2022). Revenue: CN¥711.7m (up 7.5% from FY 2022). Net income: CN¥174.0m (down 7.6% from FY 2022). Profit margin: 24% (down from 28% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥35.60, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 13x in the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥57.99, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 16x in the Chemicals industry in China.
Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥196.7m (up 43% from 3Q 2022). Net income: CN¥51.8m (up 33% from 3Q 2022). Profit margin: 26% (down from 28% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥169.1m (down 2.4% from 2Q 2022). Net income: CN¥44.3m (down 11% from 2Q 2022). Profit margin: 26% (down from 29% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Buying Opportunity • Aug 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥53.21, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 76% in 2 years. Earnings is forecast to grow by 94% in the next 2 years.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥51.75, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 16x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥44.12 per share.
Reported Earnings • May 02First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.34 in 1Q 2022). Revenue: CN¥145.0m (down 18% from 1Q 2022). Net income: CN¥28.7m (down 33% from 1Q 2022). Profit margin: 20% (down from 24% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 32%After last week's 32% share price gain to CN¥87.58, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Chemicals industry in China.
Board Change • Mar 15Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Dong Hui Pan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.